Associated Papers
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
Herencia-Ropero A et al.
Genome Medicine, 2024
39187844 (PubMed )
Supplement: 13073_2024_1370_MOESM3_ESM.xlsx › SNV
A domestic cat whole exome sequencing resource for trait discovery.
Rodney AR et al.
Scientific Reports, 2021
33785770 (PubMed )
Supplement: 41598_2021_86200_MOESM2_ESM.xlsx › CatExome40E98_-_Fcat20382
Select a paper to view details